-
UroGen Pharma's (URGN) Buy Rating Reaffirmed at D. Boral Capital
ソース: Buzz FX / 13 2 2025 11:01:11 America/New_York
UroGen Pharma's (URGN) Buy Rating Reaffirmed at D. Boral Capital Written by MarketBeat February 13, 2025 Share Link copied to clipboard. UroGen Pharma ( NASDAQ:URGN - Get Free Report ) 's stock had its "buy" rating restated by investment an
Read more...